Adverse myocardial remodeling can be reversed by medical, surgical, and device therapies leading to reduced heart failure (HF) morbidity and mortality and significant improvements in the structure and function of the failing heart. The growing population of HF patients who experience a degree of myocardial improvement should be better studied in terms of long-term outcomes and underlying biology to more clearly define the difference between recovery and remission. These investigations should also be focused in determining whether in chronic HF patients complete myocardial recovery is achievable at a meaningful rate and help us better understand, predict, and manipulate cardiac recovery.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.hfc.2016.03.007 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!